Floatz logo

Saffron

Hyperglycemia

Birjand University of Medical SciencesPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Hyperglycemia cohort.

Asset / SponsorPhaseRating
Metformin
The First Affiliated Hospital of Xiamen University
Phase 4BBB
Capecitabine
Brigham and Women's Hospital
Phase 4BB
Exenatide
Saint Luke's Health System
Phase 4BB
Olanzapine
Washington University School of Medicine
Phase 4BB
Sitagliptin
Dawn Smiley MD
Phase 4BB

View all 34 →

Same molecule, other indications

Saffron is also rated in:

hypertriglyceridemiaDormant
BB
Indicative ·
69 / 100
View asset →
HypercholesterolemiaDormant
BB
Indicative ·
68 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →